DUBLIN, Jan. 2, 2018 /PRNewswire/ -- Alkermes plc
(NASDAQ: ALKS) announced today that its corporate presentation will
be webcast live at the 36th Annual J.P. Morgan
Healthcare Conference on Tuesday, Jan. 9,
2018 at 10:30 a.m. PT
(1:30 p.m. ET/6:30 p.m. GMT) from the Westin St. Francis Hotel
in San Francisco. The presentation
will be followed by a question and answer session that will begin
at 11:00 a.m. PT (2:00 p.m. ET/7:00 p.m.
GMT). A webcast of both the presentation and question and
answer session may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin,
Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website
at www.alkermes.com.
Contact:
Jennifer Zibuda
Corporate Communications
+1 781 609 6129
View original content with
multimedia:http://www.prnewswire.com/news-releases/alkermes-corporate-presentation-to-be-webcast-at-the-36th-annual-jp-morgan-healthcare-conference-300576500.html
SOURCE Alkermes plc